José Manuel García Heredia

Assistant Proffesor

Universidad de Sevilla

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Cancer Biology Cancer Biology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

José Manuel García Heredia is an Assistant Professor at Universidad de Sevilla, Spain. His research focuses on cancer biology, particularly sarcoma treatments, breast cancer recurrence prediction using machine learning, and the role of mitochondrial function in cancer stem cell resistance. His recent publications examine gene deregulation, protein dynamics, and prognostic markers in various cancer types.

Articles (7)

Year:

2023

Year:

2023

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

José C. Riquelme

Universidad de Sevilla

SPAIN

View details

Sandra Muñoz-Galván

Universidad de Sevilla

SPAIN

View details

Jorge Garcia-Gutierrez

Profesor Titular de Universidad

Universidad de Sevilla

SPAIN

View details

Amancio Carnero

head of lab

CSIC

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

José Manuel García Heredia

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules

The Multitasker Protein: A Look at the Multiple Capabilities of NUMB

Autoencoded DNA methylation data to predict breast cancer recurrence: Machine learning models and gene-weight significance

Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells.

Sarcoma stratification by combined pH2AX and MAP17 (PDZK1IP1) levels for a better outcome on doxorubicin plus olaparib treatment.

PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.

Role of Mitochondria in Cancer Stem Cell Resistance

Collaborators (4)

José C. Riquelme

Sandra Muñoz-Galván

Jorge Garcia-Gutierrez

Amancio Carnero

Make your next move.